Cannformatics
Biotechnology company personalizing medical cannabis treatment using metabolic biomarker analysis.
About
Cannformatics is a biotechnology startup focused on personalizing medical cannabis treatment by identifying and applying saliva-based Cannabis-Responsive™ biomarkers. Their proprietary technology analyzes metabolic biomarkers to quantify individual responses to cannabis, guiding the optimization of products, dosage, and consumption methods. Initially focusing on Autism Spectrum Disorder (ASD), they plan to expand to other conditions like anxiety, pain, and neurodegenerative diseases.
Key facts
At-a-glance profile data
- Website
- cannformatics.com
- Headquarters
- San Francisco, United States
- Founded
- 2017
- Employees
- 4
- Total funding
- -
- Business model
- B2C
Tech stack
Detected on cannformatics.com, last scanned 29 Sept 2026. Run your own scan
- Observability
- Sentry
- CMS / Builders
- Wix
- CDN
- Cloudflare
- Email provider
- Microsoft 365
“Revolutionizing Autism Therapy: Cannformatics Leverages Machine Learning to Target Metabolic Imbalances.”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.
Frequently asked
How many employees does Cannformatics have?
Cannformatics has approximately 4 people on record.